Publications by authors named "Erin X Wei"
Background: Knowledge of melanoma presentations among pediatric and adolescent and young adult (AYA) patients are limited because of studies with small sample sizes.
Objective: The objective of this study was to determine the incidence trends and melanoma presentations based on age, sex, race, and ethnicity using a large cohort of diagnoses from 1997 to 2020.
Methods: A retrospective cohort study was completed using the National Childhood Cancer Registry from 1997 to 2020.
Inflammatory dermatologic diseases have long been viewed as a "skin limited" disease process. Current literature on inflammatory dermatologic diseases investigates their relationship and influence on thromboembolic states and thromboembolic complications and the understanding of their pathophysiology and molecular mechanisms.Studies specifically discuss known inflammatory skin diseases including alopecia areata, vitiligo, psoriasis, hidradenitis suppurativa, atopic dermatitis, chronic spontaneous urticaria, and autoimmune bullous diseases, and their effects on systemic inflammation, associated cardiovascular comorbidities, and thromboembolic or hypercoagulable states.
View Article and Find Full Text PDFDedicated care of Skin of Color (SOC) individuals is crucial for increasing access and culturally-sensitive management of this population [1]. Although SOC specialty clinics (SOCSC) are becoming increasingly popular, data on these is limited. We seek to describe the first detailed experience from a SOCSC.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates patient perceptions and concerns about JAK inhibitors, medications used for dermatologic diseases, to fill a gap in existing research.
- Analyzing 923 posts from popular dermatology subreddits, key themes included efficacy, side effects, and insurance/payment concerns, with major focus on medication efficacy (47%) and reported side effects (16%).
- The most common side effects reported were acne/folliculitis and nausea, while patients expressed concerns about interactions with everyday products like sunscreens and topical medications, emphasizing the need for better patient-provider communication.
Histopathologic Features of Drug Reaction With Eosinophilia and Systemic Symptoms.
Am J Dermatopathol
August 2024
Importance: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe cutaneous adverse reaction occurring 2 to 8 weeks after medication initiation. Diagnosis is clinical; RegiSCAR scoring includes biopsy "suggestive of DRESS," undefined in the literature.
Objective: This study correlates DRESS dermatopathology, culprit drugs, disease course, and outcome severity compared with maculopapular drug reactions (MDR).